Registration - Amendment

EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Period 2nd Quarter 2015 Filed Jul 18, 2015 Signed by Jonah C. Houts

Official filing
Firm
EXPRESS SCRIPTS, INC.
Client
EXPRESS SCRIPTS, INC.
Income
—
Expenses
—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 592 (114th), H.R. 804 (114th), H.R. 69 (114th), H.R. 244 (114th), H.R. 971 (114th), H.R. 1353 (114th), H.R. 2175 (114th), H.R. 1735 (114th), H.R. 818 (114th), H.R. 471 (114th), H.R. 793 (114th), H.R. 1021 (114th), H.R. 2298 (114th)

Taxation/Internal Revenue Code TAX

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 793 (114th), H.R. 244 (114th), H.R. 971 (114th), H.R. 69 (114th), H.R. 804 (114th), H.R. 592 (114th), H.R. 1353 (114th), H.R. 2175 (114th), H.R. 1735 (114th), H.R. 2298 (114th), H.R. 818 (114th), H.R. 471 (114th), H.R. 1021 (114th)

Health Issues HCR

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 971 (114th), H.R. 1735 (114th), H.R. 471 (114th), H.R. 244 (114th), H.R. 592 (114th), H.R. 2298 (114th), H.R. 804 (114th), H.R. 1021 (114th), H.R. 818 (114th), H.R. 1353 (114th), H.R. 793 (114th), H.R. 2175 (114th), H.R. 69 (114th)

Postal POS

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 1021 (114th), H.R. 471 (114th), H.R. 2175 (114th), H.R. 1735 (114th), H.R. 592 (114th), H.R. 971 (114th), H.R. 1353 (114th), H.R. 804 (114th), H.R. 2298 (114th), H.R. 793 (114th), H.R. 818 (114th), H.R. 69 (114th), H.R. 244 (114th)

Labor Issues/Antitrust/Workplace LBR

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 69 (114th), H.R. 804 (114th), H.R. 471 (114th), H.R. 592 (114th), H.R. 1021 (114th), H.R. 818 (114th), H.R. 971 (114th), H.R. 244 (114th), H.R. 2175 (114th), H.R. 1353 (114th), H.R. 2298 (114th), H.R. 1735 (114th), H.R. 793 (114th)

Medicare/Medicaid MMM

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 1353 (114th), H.R. 818 (114th), H.R. 471 (114th), H.R. 971 (114th), H.R. 244 (114th), H.R. 592 (114th), H.R. 1021 (114th), H.R. 804 (114th), H.R. 2175 (114th), H.R. 1735 (114th), H.R. 2298 (114th), H.R. 69 (114th), H.R. 793 (114th)

Pharmacy PHA

Legislative and regulatory issues that affect the prescription drug benefit or prescription drug affordability, including: HR244 (MAC Pricing); HR471 (Controlled Substances Registration); HR592 (Pharmacy Provider Status); HR69 (ASP Prompt Pay Exclusion); HR793 (Any Willing Pharmacy); HR804 (Access to Medicare Data); HR818 (PRIME Act); HR971 (OPEN Act); HR1021 (PIMA); HR1353 (New Therapeutic Entities); HR1735 (NDAA); HR2175 (FEHBP Transparency); HR2298 (Medicare Rx Abuse Prevention); S31 (Direct Negotiation); S314 (Pharmacy Provider Status); S1083 (Medicare Rebates); S1190 (Any Willing Pharmacy); S1364 (Medicaid Generic Rebates); S1376 (NDAA); S1431(Rx Abuse Prevention & Treatment).

LobbyistCovered position, as disclosed
MICHAEL DONNELLY New —

Bills named: H.R. 592 (114th), H.R. 1021 (114th), H.R. 244 (114th), H.R. 1735 (114th), H.R. 2298 (114th), H.R. 1353 (114th), H.R. 69 (114th), H.R. 818 (114th), H.R. 804 (114th), H.R. 471 (114th), H.R. 971 (114th), H.R. 2175 (114th), H.R. 793 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.